Chromogenic In Situ Hybridization and p16/Ki67 Dual Staining on Formalin-Fixed Paraffin-Embedded Cervical Specimens: Correlation with HPV-DNA Test, E6/E7 mRNA Test, and Potential Clinical Applications
Table 1
Summary of results from histological diagnosis, HPV-DNA and mRNA tests, HPV viral load, CISH, and p16/Ki67 dual stain.
Case
Histological diagnosis
HR HPV-DNA test result
HC2 viral load (RLU/CO)*
E6/E7 mRNA test result
Type specific mRNA test result**
HPV CISH† signal
P16/Ki67 Dual stain result
1
CIN1
Positive
63.5
Negative
—
P
Negative
2
CIN1
Positive
516.61
Negative
—
D
Negative
3
CIN3
Positive
15.79
Negative
—
Negative
Positive
4
CIN2
Positive
146.77
Positive
16
D/P
Positive
5
CIN2
Positive
1283.97
Negative
—
D/P
Positive
6
CIN1
Positive
298.55
Negative
—
D
Negative
7
CIN3
Positive
1529.35
Positive
16, 31
D/P
Positive
8
CIN3
Positive
2207.8
Positive
31
D/P
Positive
9
CIN1
Positive
2.06
Negative
—
D
Negative
10
CIN2
Positive
216.93
Positive
31
D/P
Positive
11
CIN1
Positive
6.7
Negative
—
Negative
Negative
12
CIN2
Positive
84.32
Positive
31
Negative
Positive
13
CIN3
Positive
10.56
Positive
16
D/P
Positive
14
CIN3
Positive
338.02
Positive
16
D/P
Positive
15
CIN1
Positive
1211.84
Positive
33
D/P
Positive
16
CIN3
Positive
3.3
Positive
16
P
Positive
17
CIN1
Positive
155.79
Positive
16
D
Negative
18
CIN1
Positive
28.81
Negative
—
Negative
Positive
19
CIN2
Positive
34.82
Negative
—
D
Positive
20
CIN3
Positive
913.36
Negative
—
D
Positive
21
CIN2
Positive
1536.02
Positive
16
P
Negative
22
CIN2
Positive
107.22
Positive
18, 45
D/P
Positive
23
CIN1
Positive
75.86
Negative
—
D/P
Negative
24
CIN2
Positive
675.75
Positive
16
D/P
Positive
25
CIN2
Positive
596.84
Positive
16
D/P
Positive
26
CIN3
Positive
1914.17
Positive
16
D/P
Positive
27
CIN2
Positive
570.26
Positive
16, 45
D/P
Positive
28
CIN1
Positive
783.56
Negative
—
D
Negative
29
CIN1
Negative
—
Negative
—
Negative
Negative
30
CIN3
Positive
3.93
Positive
16
P
Positive
31
CIN3
Positive
968.56
Positive
31
D/P
Positive
32
CIN1
Positive
926.05
Positive
31
Invalid
Negative
33
CIN2
Negative
—
Positive
31
Invalid
Positive
34
CIN1
Positive
45
Negative
—
D
Negative
35
CIN3
Positive
117
Positive
16
D/P
Positive
36
CIN1
Positive
237.48
Positive
16
Invalid
Negative
37
CIN1
Positive
5.31
Positive
18, 31
Negative
Negative
38
CIN1
Positive
204.42
Positive
45
Negative
Negative
39
CIN3
Positive
663.26
Positive
33
Negative
Positive
40
CIN3
Positive
38.61
Positive
16
Negative
Positive
41
CIN1
Positive
10.11
Positive
33
D/P
Positive
42
CIN1
Positive
137.88
Negative
—
D
Negative
43
CIN3
Positive
6.21
Positive
16
Negative
Positive
44
CIN2
Positive
2663.26
Positive
31
D/P
Positive
45
SCC
Positive
1549.74
Positive
33
D/P
Positive
46
CIN2
Positive
894.17
Positive
16
P
Positive
47
CIN1
Positive
20.47
Negative
—
Negative
Negative
48
CIN1
Positive
26.23
Negative
—
Negative
Negative
49
CIN1
Positive
787.16
Positive
31
Negative
Negative
50
CIN1
Positive
676.46
Positive
16
D/P
Negative
51
CIN3
Positive
2.36
Positive
16
P
Positive
52
CIN3
Positive
1.45
Positive
18
P
Positive
53
CIN3
Positive
111.95
Positive
16, 18
D/P
Positive
54
CIN3
Positive
544.41
Positive
16
D/P
Positive
55
CIN2
Positive
663.21
Positive
16
D/P
Positive
56
CIN1
Negative
—
Negative
—
Negative
Negative
57
CIN2
Positive
1569.56
Positive
18
D/P
Positive
58
CIN3
Positive
758.66
Positive
16
D/P
Positive
59
CIN2
Positive
130.13
Positive
16
D/P
Positive
60
CIN3
Positive
87.01
Positive
16
P
Positive
61
CIN3
Positive
968.56
Positive
31
D/P
Positive
62
CIN2
Positive
6.21
Positive
16
P
Positive
63
CIN3
Positive
24.01
Positive
16
P
Positive
Relative light unit in relation to control (RLU/CO).
**HPV genotype(s) detected by Nuclisens EasyQ HPV mRNA test. †D: diffuse; P: punctated; D/P: mixed diffuse/punctated.